HeatherLMcArthurDO

PubMed

• Phase IB Randomized, Double-Blinded, Placebo-Controlled, Dose Escalation Study of Polyphenon E in Women with Hormone Receptor-Negative Breast Cancer.
  Wang, A., Ahmed, A., Arun, B., Hudis, C., Hershman, D. L., Hibshoosh, H., Greenlee, H., McArthur, H. L., Chang, J., Crew, K. D., Vornik, L., Terry, M. B., Rimawi, M., ...> ;Cancer Prev Res (Phila). 2012 Sep
• Adjuvant trastuzumab reduces locoregional recurrence in women who receive breast-conservation therapy for lymph node-negative, human epidermal growth factor receptor 2...
  Ho, A., Kiess, A. P., McCormick, B., Hudis, C. A., McArthur, H. L., Mahoney, K., Morris, P. G., Patil, S.> ;Cancer. 2012 Apr 15
• Adjuvant trastuzumab with chemotherapy is effective in women with small, node-negative, HER2-positive breast cancer.
  Hudis, C. A., McArthur, H. L., Howard, J., Mahoney, K. M., Norton, L., Jacks, L. M., Morris, P. G., Patil, S.> ;Cancer. 2011 Dec 15
• Troponin I and C-reactive protein are commonly detected in patients with breast cancer treated with dose-dense chemotherapy incorporating trastuzumab and lapatinib.
  Abbruzzi, A., Moy, B., Chen, C., Dang, C. T., Hudis, C. A., Winer, E., McArthur, H. L., Norton, L., Fleisher, M., Dickler, M., Lin, N., Morris, P. G., Steingart, R., L...> ;Clin Cancer Res. 2011 May 15
• A feasibility study of bevacizumab plus dose-dense doxorubicin-cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel in early-stage breast cancer.
  Seidman, A., Nulsen, B., Merali, C., Dang, C., Hudis, C. A., Lake, D., D'Andrea, G., McArthur, H. L., Rugo, H., Sealey, J. E., Grothusen, J., Park, J., Laragh, J. H., ...> ;Clin Cancer Res. 2011 May 15
• Aromatase inhibitor strategies in metastatic breast cancer.
  McArthur, H. L., Morris, P. G.> ;Int J Womens Health. 2010
• Integrated positron emission tomography/computed tomography may render bone scintigraphy unnecessary to investigate suspected metastatic breast cancer.
  Hudis, C. A., Lynch, C., McArthur, H. L., Howard, J., Feeney, J. N., Dickler, M., Jochelson, M., Morris, P. G., Larson, S. M., Patil, S.> ;J Clin Oncol. 2010 Jul 1
• Dose-dense chemotherapy for breast cancer: what does the future hold?
  Hudis, C., McArthur, H. L., Norton, L., Morris, P. G.> ;Future Oncol. 2010 Jun
• Update on administration of adjuvant trastuzumab.
  McArthur, H. L.> ;Clin Adv Hematol Oncol. 2010 May
• Dose-dense adjuvant Doxorubicin and cyclophosphamide is not associated with frequent short-term changes in left ventricular ejection fraction.
  Nulsen, B., Moy, B., Chen, C., Dang, C. T., Hudis, C. A., Winer, E., McArthur, H. L., Rugo, H., Norton, L., Godfrey, L., Dickler, M., Lin, N., Morris, P. G., Steingart...> ;J Clin Oncol. 2009 Nov 11
• Trastuzumab: a picky partner?
  Hudis, C. A., McArthur, H. L.> ;Clin Cancer Res. 2009 Oct 15
• Therapeutic options for metastatic breast cancer.
  Hudis, C. A., McArthur, H. L., Morris, P. G.> ;Expert Opin Pharmacother. 2009 Apr 09
• Effectiveness of a letter notification program for women with early-stage breast cancer eligible for extended adjuvant letrozole.
  Speers, C. H., Kennecke, H. F., McArthur, H. L., Olivotto, I. A., Gelmon, K. A., O'Reilly, S. E., Ellard, S. L.> ;J Clin Oncol. 2009 Mar 20
• An overview of HER-targeted therapy with lapatinib in breast cancer.
  McArthur, H.> ;Adv Ther. 2009 Apr 15
• Advances in adjuvant chemotherapy of early stage breast cancer.
  Hudis, C. A., McArthur, H. L.> ;Cancer Treat Res. 2008
• Biomarkers in breast cancer.
  McArthur, H. L., Dickler, M. N.> ;Cancer Biol Ther. 2008 Jan
• Join now to see all